Human Genome Epidemiology Literature Finder
|
Records 1 - 15 (of 15 Records) |
| Query Trace: Breast Neoplasms and AHR[original query] |
|---|
| Genetic polymorphisms and transcriptional pattern analysis of CYP1A1, AhR, GSTM1, GSTP1 and GSTT1 genes in breast cancer. International journal of molecular medicine 2001 Jul 8 (1): 79-87. Dialyna I A, Arvanitis D A, Spandidos D |
| Interaction between genetic polymorphism of cytochrome P450-1B1 and environmental pollutants in breast cancer risk. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2004 Feb 13 (1): 83-6. Saintot M, Malaveille C, Hautefeuille A, Gerber M |
| Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Aug 14 (8): 1998-2003. Le Marchand Loïc, Donlon Timothy, Kolonel Laurence N, Henderson Brian E, Wilkens Lynne |
| Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk. Pharmacogenetics and genomics 2006 Apr 16 (4): 237-43. Long Ji-Rong, Egan Kathleen M, Dunning Lisa, Shu Xiao-Ou, Cai Qiuyin, Cai Hui, Dai Qi, Holtzman Jordan, Gao Yu-Tang, Zheng W |
| Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival. Pharmacogenetics and genomics 2007 May 17 (5): 331-8. Long Ji-Rong, Cai Qiuyin, Shu Xiao-Ou, Cai Hui, Gao Yu-Tang, Zheng W |
| Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Jan 14 (2): 446-54. Hassan Saima, Baccarelli Andrea, Salvucci Ombretta, Basik Ma |
| The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer. Breast cancer research and treatment 2010 Apr 120 (3): 663-9. Yi Chunhui, Mu Lina, de la Longrais Irene A Rigault, Sochirca Olga, Arisio Riccardo, Yu Herbert, Hoffman Aaron E, Zhu Yong, Katsaro Dionyssi |
| Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women. International journal of cancer. Journal international du cancer 2009 Aug 125 (4): 837-43. Sangrajrang Suleeporn, Sato Yasunori, Sakamoto Hiromi, Ohnami Sumiko, Laird Nan M, Khuhaprema Thiravud, Brennan Paul, Boffetta Paolo, Yoshida Teruhi |
| Evaluation of functional genetic variants for breast cancer risk: results from the Shanghai breast cancer study. American journal of epidemiology 2011 May 173 (10): 1159-70. Zhang Ben, Beeghly-Fadiel Alicia, Lu Wei, Cai Qiuyin, Xiang Yong-Bing, Zheng Ying, Long Jirong, Ye Chuanzhong, Gu Kai, Shu Xiao-Ou, Gao Yutang, Zheng W |
| Analysis of the AHR gene proximal promoter GGGGC-repeat polymorphism in lung, breast, and colon cancer. Toxicology and applied pharmacology 2015 Jan 282 (1): 30-41. Spink Barbara C, Bloom Michael S, Wu Susan, Sell Stewart, Schneider Erasmus, Ding Xinxin, Spink David |
| Lack of association between the aryl hydrocarbon receptor rs2066853 polymorphism and breast cancer: A meta-analysis on Ahr polymorphism and breast cancer. Genetics and molecular research : GMR 2015 14 (4): 16162-8. Li Y, Qin H Z, Song Q, Wu X D, Zhu J |
| Predictive polymorphisms for breast cancer in postmenopausal Mexican women. Journal of cancer research and therapeutics 0 14 (3): 640-646. Sierra-Martinez Mónica, Hernández-Cadena Leticia, García-Sánchez José Rubén, Acosta-Altamirano Gustavo, Palacios-Reyes Carmen, Alonso-Themann Patricia García, García-Ortiz Liliana, Quintas-Granados Laura Itzel, Reyes-Hernández Octavio Dani |
| The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study. Frontiers in oncology 2021 6 11 642768. Tryggvadottir Helga, Sandén Emma, Björner Sofie, Bressan Alessandra, Ygland Rödström Maria, Khazaei Somayeh, Edwards Dean P, Nodin Björn, Jirström Karin, Isaksson Karolin, Borgquist Signe, Jernström Hele |
| Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL. Annals of oncology : official journal of the European Society for Medical Oncology 2021 1 32 (4): 488-499. Martin M, Zielinski C, Ruiz-Borrego M, Carrasco E, Turner N, Ciruelos E M, Muñoz M, Bermejo B, Margeli M, Anton A, Kahan Z, Csöszi T, Casas M I, Murillo L, Morales S, Alba E, Gal-Yam E, Guerrero-Zotano A, Calvo L, de la Haba-Rodriguez J, Ramos M, Alvarez I, Garcia-Palomo A, Huang Bartlett C, Koehler M, Caballero R, Corsaro M, Huang X, Garcia-Sáenz J A, Chacón J I, Swift C, Thallinger C, Gil-Gil |
| Association of progesterone receptor status with 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer. BMC cancer 2023 4 23 (1): 330. Ma Sung Jun, Gill Jasmin, Yendamuri Keerti, Chatterjee Udit, Waldman Olivia, Dunne-Jaffe Cynthia, Fekrmandi Fatemeh, Shekher Rohil, Iovoli Austin, Yao Song, Oladeru Oluwadamilola T, Singh Anurag |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: